Cardiff Oncology (CRDF) Shares Issued (2011 - 2026)

Cardiff Oncology has reported Shares Issued for 8 years, with the latest figure at $6.3 million in Q4 2025.

• Quarterly Shares Issued fell 24.75% year-over-year to $6.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (down 24.75% YoY) and the FY2025 annual result came in at $6.3 million, down 24.75% from the prior year.
• Shares Issued declined to $6.3 million in Q4 2025 per CRDF's latest filing, from $6.3 million in the prior quarter.
• Over five years, Shares Issued peaked at $8.3 million in Q4 2024 and troughed at $668803.0 in Q1 2025.
• A 3-year average of $5.3 million and a median of $6.3 million in 2025 frame the typical range for Shares Issued.
• The widest YoY moves for Shares Issued: up 42.73% in 2025, down 24.75% in 2025.
• Over 3 years, Shares Issued stood at $6.7 million in 2023, then grew by 25.32% to $8.3 million in 2024, then slipped by 24.75% to $6.3 million in 2025.
• According to Business Quant data, Shares Issued over the past three periods registered $6.3 million, $6.3 million, and $4.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.